Libo Pharma Corp. (TPEX:7888)
Taiwan · Delayed Price · Currency is TWD 28.90
-0.90 (-3.02%)
At close: Sep 2, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 2.17 billion as of September 3, 2026.
Market Cap
2.17B
Enterprise Value
1.53B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
28.90
ChartMarket Cap Chart
Since December 23, 2025, Libo Pharma's market cap has decreased from 3.55B to 2.17B, a decrease of -38.71%. That is a compound annual growth rate of -50.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 2.21B | -40.24% |
| Dec 31, 2025 | 3.70B | 4.35% |
| Dec 23, 2025 | 3.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taho Pharmaceuticals | 7.99B |
| Pharmasaga | 7.79B |
| TEH SENG Pharmaceutical Mfg. | 2.58B |
| Gin Hwa Biotech Incorporation | 1.96B |
| Timing Pharmaceutial | 1.74B |
| Anbogen Therapeutics | 1.73B |
| TSA International | 1.58B |
| Anya Biopharm | 1.52B |